Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download


  Free Subscription

Articles published in Invest Radiol

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    August 2020
  1. RAI A, MacGregor K, Hunt B, Gontar A, et al
    Proof of Concept: Phantom Study to Ensure Quality and Safety of Portable Chest Radiography Through Glass During the COVID-19 Pandemic.
    Invest Radiol. 2020 Aug 7. doi: 10.1097/RLI.0000000000000716.
    PubMed     Abstract available

    June 2020
  2. WALLER JV, Allen IE, Lin KK, Diaz MJ, et al
    The Limited Sensitivity of Chest Computed Tomography Relative to Reverse Transcription Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Systematic Review on COVID-19 Diagnostics.
    Invest Radiol. 2020 Jun 16. doi: 10.1097/RLI.0000000000000700.
    PubMed     Abstract available

    April 2020
  3. LYU P, Liu X, Zhang R, Shi L, et al
    The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics.
    Invest Radiol. 2020 Apr 17. doi: 10.1097/RLI.0000000000000689.
    PubMed     Abstract available

    March 2020
  4. XIONG Y, Sun D, Liu Y, Fan Y, et al
    Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes.
    Invest Radiol. 2020 Mar 3. doi: 10.1097/RLI.0000000000000674.
    PubMed     Abstract available

    February 2020
  5. LI K, Wu J, Wu F, Guo D, et al
    The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia.
    Invest Radiol. 2020 Feb 29. doi: 10.1097/RLI.0000000000000672.
    PubMed     Abstract available

  6. WU J, Wu X, Zeng W, Guo D, et al
    Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features.
    Invest Radiol. 2020 Feb 21. doi: 10.1097/RLI.0000000000000670.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.